1
Participants
Start Date
April 30, 2006
Primary Completion Date
November 30, 2013
Study Completion Date
November 30, 2013
long-acting injectable risperidone
One week of oral risperidone dosage started at 2mg for the first day and then increased to 4mg. If no side effects are noted, participants are started on the long-acting risperidone. The usual dosage of long-acting risperidone in the study will be 25mg every 2 weeks for a total of 12 weeks. The medication will be administered intramuscularly via injection.
The Zucker Hillside Hospital, Glen Oaks
SUNY Downstate Medical Center, Brooklyn
Lead Sponsor
The Zucker Hillside Hospital
OTHER
National Alliance for Research on Schizophrenia and Depression
OTHER
Northwell Health
OTHER